drugset / Trial / NCT02735473

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders

NCT02735473

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The primary outcome measures are cognitive measures.

Timeline

Start
2016-06
Primary completion
2021-09-10
Completion
2021-09-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Choline Bitartrate Small molecule 19 mg/kg